ArticleJournal of virology2025
Rabies virus utilizes neuropilin 2 as an endocytic receptor to trigger TGFBR1-mediated actin polymerization.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Dog bite-associated pathogens: advances in pathogenic mechanisms and systemic clinical consequences in humans.One health (Amsterdam, Netherlands) · 2026Review
- Adaptation of wild-type rabies virus on vaccine producing cell line and its quantification by peroxidase-based immunostaining.Archives of virology · 2026Article
- GRP78 promotes rabies virus entry through interacting with viral receptors.Journal of virology · 2026Article
- Knockout of key receptors (PDGFRA and NRP2) in the guinea pig model blocks direct and endocytic pathways of CMV cell entry.The Journal of general virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Rabies virus (RABV), belonging to the rhabdovirus, is a typical large virus that enters cells via clathrin-mediated endocytosis (CME). RABV-containing pits are only partially clathrin-coated and require local actin polymerization for efficient internalization. This unconventional entry process suggests that a specific receptor may be required to initiate actin polymerization during RABV entry. Here, we found that RABV uses the cell membrane protein neuropilin 2 (NRP2) to initiate F-actin polymerization. NRP2 is required for RABV infection and directly interacts with RABV glycoprotein. An antibody against the ectodomain of NRP2 and the soluble ectodomain of NRP2 blocked RABV infection in cells. Expression of human NRP2 in non-susceptible DU145 cells enabled RABV infection. We further found that NRP2 interacted with transforming growth factor-β receptor I (TGFBR1), triggering TGFBR1/2-Cdc42-mediated F-actin polymerization. Vesicular stomatitis virus, another prototypical rhabdovirus, also uses a similar mechanism to enter cells. Our findings demonstrate that NRP2 is a novel receptor for RABV entry by transducing the signal of viral binding across the plasma membrane to initiate actin polymerization. NRP2 may represent one of the long-sought molecules that facilitate large pathogen cell entry via CME.IMPORTANCERabies virus (RABV) enters cells via clathrin-mediated endocytosis (CME), but RABV-containing pits are only partially clathrin-coated, requiring actin polymerization for efficient entry. However, how the virus triggers the actin polymerization remains unclear. Here, we found that the cell membrane protein neuropilin 2 (NRP2) is required for RABV infection and directly interacts with RABV glycoprotein. An antibody against the ectodomain of NRP2 and the soluble ectodomain of NRP2 blocked RABV infection in cells. Expression of human NRP2 in non-susceptible DU145 cells enabled RABV infection. We further found that NRP2 interacted with transforming growth factor-β receptor I (TGFBR1), triggering TGFBR1/2-Cdc42-mediated F-actin polymerization. Vesicular stomatitis virus, another prototypical rhabdovirus, also uses a similar mechanism to enter cells. Our findings demonstrate that NRP2 is a novel receptor for RABV entry by initiating actin polymerization and may represent one of the long-sought molecules that facilitate large pathogen cell entry via CME.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.